REAL-WORLD EFFECTIVENESS OF USTEKINUMAB IN PATIENTS WITH ULCERATIVE COLITIS IN THE UNITED STATES OF AMERICA

被引:0
|
作者
Burbage, Sabree
Harvey, Niamh
Godwin, Bridget
Meadows, Rachael
Knight, Hannah
Zhao, Ruizhi
Kachroo, Sumesh
机构
关键词
D O I
10.1093/ibd/izae020.189
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
izae020189
引用
收藏
页码:S86 / S87
页数:2
相关论文
共 50 条
  • [41] Ustekinumab in refractory Ulcerative Colitis: single-center, real-world experience
    Herrera De Guise, C. M.
    Mayorga Ayala, L. F.
    Robles Alonso, V.
    Serra Ruiz, X.
    Cespedes Martinez, E.
    Lastiri Gonzalez, E.
    Perez Martinez, Z.
    Oller Jimenez, E.
    Casellas, F.
    Borruel Sainz, N.
    [J]. JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1709 - I1709
  • [42] Predictors of corticosteroid-free remission after initiation of ustekinumab for ulcerative colitis: a real-world, multicenter cohort study in the United States
    Dalal, R.
    Esckilsen, S.
    Barnes, E.
    McClure, E.
    Goodrick, H.
    Allegretti, J.
    [J]. JOURNAL OF CROHNS & COLITIS, 2021, 15 : S348 - S349
  • [43] Real-world evidence of tofacitinib effectiveness and safety in patients with refractory ulcerative colitis
    Lair-Mehiri, Loriane
    Stefanescu, Carmen
    Vaysse, Thibaut
    Laharie, David
    Roblin, Xavier
    Rosa, Isabelle
    Treton, Xavier
    Abitbol, Vered
    Amiot, Aurelien
    Bouguen, Guillaume
    Dib, Nina
    Fumery, Mathurin
    Pariente, Benjamin
    Carbonnel, Franck
    Peyrin-Biroulet, Laurent
    Simon, Marion
    Viennot, Stephanie
    Bouhnik, Yoram
    [J]. DIGESTIVE AND LIVER DISEASE, 2020, 52 (03) : 268 - 273
  • [44] One-year effectiveness and safety of ustekinumab in ulcerative colitis: a multicenter real-world study from Italy
    Chiappetta, Michele Francesco
    Viola, Anna
    Mastronardi, Mauro
    Turchini, Laura
    Carparelli, Sonia
    Orlando, Adele
    Biscaglia, Giuseppe
    Miranda, Agnese
    Guida, Laura
    Costantino, Giuseppe
    Scaldaferri, Franco
    Bossa, Fabrizio
    Renna, Sara
    Cappello, Maria
    Alibrandi, Angela
    Orlando, Ambrogio
    Armuzzi, Alessandro
    Fries, Walter
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (11) : 1483 - 1489
  • [45] Long-term real-world data of Ustekinumab in Ulcerative Colitis - the Stockholm Ustekinumab study - STOCUSTE
    Sabhan, H.
    [J]. JOURNAL OF CROHNS & COLITIS, 2023, 17 : 747 - 747
  • [46] Real-World Effectiveness of Belimumab in Patients with SLE in the United States
    Bell, Christopher
    Rubin, Bernie
    Worley, Karen
    Germain, Guillaume
    Laliberte, Francois
    MacKnight, Sean D.
    Urosevic, Ana
    Duh, Mei Sheng
    [J]. ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 685 - 686
  • [47] Real-world use and effectiveness of golimumab for ulcerative colitis in Canada
    Bressler, B.
    Williamson, M.
    Camacho, F.
    Sattin, B.
    Steinhart, A. H.
    [J]. JOURNAL OF CROHNS & COLITIS, 2016, 10 : S396 - S396
  • [48] Real World Effectiveness of Advanced Therapies Among Patients With Moderate-to-Severe Ulcerative Colitis in the United States
    Smith, Timothy W.
    DiBonaventura, Marco
    Gruben, David
    Bargo, Danielle
    Salese, Leonardo
    Quirk, Daniel
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S353 - S353
  • [49] Comparison of Real-World Outcomes of Adalimumab (ADA) and Infliximab (IFX) for Patients With Ulcerative Colitis (UC) in the United States
    Sandborn, William
    Sakuraba, Atsushi
    Ozbay, A. Burak
    Sorg, Rachael A.
    Reichmann, William
    Chao, Jingdong
    Skup, Martha
    [J]. GASTROENTEROLOGY, 2015, 148 (04) : S272 - S272
  • [50] Real-World Comparison of the Effectiveness between Ustekinumab and Vedolizumab in Patients with Ulcerative Colitis Exposed to at least One Anti-TNF Agent
    Fumery, Mathurin
    Serrero, Melanie
    Bouguen, Guillaume
    Amiot, Aurelien
    Altwegg, Romain
    Nachury, Maria
    Vuitton, Lucine
    Treton, Xavier
    Caillo, Ludovic
    Pereira, Bruno
    Buisson, Antony
    [J]. JOURNAL OF CROHNS & COLITIS, 2024,